These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9704451)

  • 81. [What is the therapeutic effectiveness of organofluorine emulsions substituting in acute blood loss?].
    Iarkochkin VS; Volos OP; Koziner VB
    Gematol Transfuziol; 1991 Oct; 36(10):38-9. PubMed ID: 1778394
    [No Abstract]   [Full Text] [Related]  

  • 82. [The standardization of colloid osmotic pressure of blood substitutes with a perfluorocarbon base].
    Draffehn J; Reichelt H; Sauer S
    Pharmazie; 1991 Jul; 46(7):525-7. PubMed ID: 1723803
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
    Frietsch T; Lenz C; Waschke KF
    Dtsch Med Wochenschr; 2000 Apr; 125(15):465-72. PubMed ID: 10800445
    [No Abstract]   [Full Text] [Related]  

  • 84. Perfluorocarbons and haemoglobin solutions: will they ever reach clinical practice?
    Lamy M; Deby-Dupont G
    Acta Anaesthesiol Belg; 2003; 54(4):299-300. PubMed ID: 14719348
    [No Abstract]   [Full Text] [Related]  

  • 85. Elaboration of fluorocarbon emulsions with improved oxygen-carrying capabilities.
    Riess JG; Krafft MP
    Adv Exp Med Biol; 1992; 317():465-72. PubMed ID: 1288158
    [No Abstract]   [Full Text] [Related]  

  • 86. Hemoglobin solutions as blood substitutes: an overview.
    Bellelli A; Brunori M
    Ann Ital Med Int; 1986 Dec; 1(4):275-80. PubMed ID: 3079371
    [No Abstract]   [Full Text] [Related]  

  • 87. The safety and efficacy of perfluorochemical emulsions as blood substitutes.
    Sloviter HA
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):459-61. PubMed ID: 3052647
    [No Abstract]   [Full Text] [Related]  

  • 88. [Prospects of treating acute circulatory hypoxia with perfluorocarbon emulsions].
    Goncharov OG; Kuznetsova IN; Sedova LA
    Vestn Khir Im I I Grek; 1986 Jun; 136(6):132-6. PubMed ID: 3750705
    [No Abstract]   [Full Text] [Related]  

  • 89. Chemistry of fluorocarbons in biomedical use.
    Moore RE; Clark LC
    Int Anesthesiol Clin; 1985; 23(1):11-24. PubMed ID: 3980102
    [No Abstract]   [Full Text] [Related]  

  • 90. [Artificial oxygen carriers -- a critical analysis of current developments].
    Dinkelmann S; Northoff H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):47-54. PubMed ID: 12522731
    [No Abstract]   [Full Text] [Related]  

  • 91. [Perftoran--blood substitute with oxygen transport function].
    Golubev AM
    Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539
    [No Abstract]   [Full Text] [Related]  

  • 92. Oxygen transport in vivo by means of perfluorochemical preparations.
    Geyer RP
    N Engl J Med; 1982 Jul; 307(5):304-5. PubMed ID: 6806660
    [No Abstract]   [Full Text] [Related]  

  • 93. [Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes].
    Afonin NI; Rybolovleva IuR; Putiatina TK; Aprosin IuD; Doronina NN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):12-4. PubMed ID: 7178045
    [No Abstract]   [Full Text] [Related]  

  • 94. [Correction of the indices of physicochemical homeostasis by the infusion of a perfluorocarbon emulsion in treating hemorrhagic shock in dogs].
    Kuznetsova IN; Gerbut KA
    Gematol Transfuziol; 1987 Jul; 32(7):36-40. PubMed ID: 3666390
    [No Abstract]   [Full Text] [Related]  

  • 95. An overview of perfluoroctylbromide--application as a synthetic oxygen carrier and imaging agent for X-ray, ultrasound and nuclear magnetic resonance.
    Long DM; Long DC; Mattrey RF; Long RA; Burgan AR; Herrick WC; Shellhamer DF
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):411-20. PubMed ID: 3052645
    [No Abstract]   [Full Text] [Related]  

  • 96. Stability and stabilization of fluorocarbon emulsions destined for injection.
    Riess JG; Postel M
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):819-30. PubMed ID: 1391516
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Design, synthesis and evaluation of fluorocarbons and surfactants for in vivo applications. New perfluoroalkylated polyhydroxylated surfactants.
    Riess JG; Arlen C; Greiner J; Le Blanc M; Manfredi A; Pace S; Varescon C; Zarif L
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):421-30. PubMed ID: 3052646
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Modeling of oxygen transport in blood-perfluorocarbon emulsion mixtures: Part II: tissue oxygenation.
    Patel S; Mehra A
    ASAIO J; 1998; 44(3):157-65. PubMed ID: 9617944
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Novel compositions of emulsified perfluorochemicals for biological uses.
    Sharma SK; Lowe KC; Davis SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):447-50. PubMed ID: 3179481
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A bloodless revolution. A growing interest in artificial blood substitutes has resulted in new products that could soon improve transfusion medicine.
    Rinaldi A
    EMBO Rep; 2005 Aug; 6(8):705-8. PubMed ID: 16065060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.